ArticleMedicine2026
Mapping antibiotic resistance research in Latin America: A bibliometric analysis of patterns, gaps, and future directions.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntibiotic resistance (ABR) is a natural phenomenon where microorganisms develop resistance to the harmful effects of medications. In Latin America and the Caribbean, ABR has garnered significant interest, particularly in low- and middle-income countries, due to heterogeneous factors that predispose to high ABR rates.
methodsA bibliometric study was conducted using the Web of Science database. Bibliometric indicators were calculated using the bibliometrix package in R, and network analyses were performed using VOSviewer.
resultsThree thousand six hundred two articles were identified, with an annual growth rate of 31.65%. Brazil led with 1577 articles (43.8%), followed by Mexico (12%). The most productive authors were Nilton Lincopan (59 articles) and Ana Cristina Gales (39 articles). The Brazilian Journal of Microbiology published the most articles (133 articles). The University of São Paulo was the most productive institution (537 articles). The most cited article was by Hendriksen et al (2019) with 682 citations. Keyword analysis revealed that the most notable bacteria were Escherichia coli and Enterobacteriaceae, other common themes were genes, plasmid, epidemiology, and outbreak. The most recent keywords appear to be colistin resistance, polymyxins.
conclusionScientific production on ABR in Latin America has increased, led by Brazil and Mexico. However, significant gaps persist in research capacity and policy implementation in other countries, hindering effective regional strategies. Efforts must prioritize equity in knowledge dissemination and international collaboration to translate evidence into interventions that reduce resistance-related mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.